How to Get GLP-1 Without Insurance: Complete 2026 Guide

If your insurance doesn't cover Wegovy, Zepbound, or any other GLP-1 weight-loss medication, you are not alone. Roughly two-thirds of commercially insured adults have no obesity-medication coverage at all, and Medicare has historically excluded weight-loss drugs from Part D coverage entirely. The good news: in 2026, there are more legal, affordable paths to GLP-1 access than ever before. The bad news: choosing the right one requires understanding a confusing landscape of compounding pharmacies, manufacturer coupons, and telehealth providers.

This guide walks through every realistic option for getting a GLP-1 medication without insurance, from cheapest to most expensive, with the safety and legal caveats for each. By the end, you should know exactly which path fits your situation. To get a personalized cost estimate, run your numbers through our GLP-1 savings calculator.

Key Takeaways

• Compounded semaglutide via reputable telehealth providers is currently the cheapest legal path: $129–$249/month.
• Manufacturer savings cards (Wegovy, Zepbound) can bring brand-name cost as low as $499/month for commercially insured patients without obesity coverage.
• LillyDirect vial program offers Zepbound at $349 (starter dose) to $499/month for cash-pay patients.
• International pharmacies (Canadian, UK) are not legal for U.S. patients in most cases — be very cautious.
• Off-label Ozempic is harder to obtain in 2026 due to insurance audits and supply allocation.
• Always verify your provider with LegitScript or state pharmacy board records before paying.

Option 1: Compounded GLP-1 via Telehealth (Cheapest Legal Path)

In 2026, the lowest-cost legal path to GLP-1 medication is compounded semaglutide or tirzepatide dispensed through a licensed telehealth provider. Pricing typically runs $129–$399/month depending on the drug, dose, and provider.

How it works

1. You complete an online medical intake with a telehealth provider.
2. A licensed prescriber (MD, NP, or PA) reviews your intake and, if appropriate, writes a prescription for compounded semaglutide or tirzepatide.
3. The prescription is filled by a compounding pharmacy — either a 503A pharmacy (state-licensed, individualized prescriptions) or a 503B outsourcing facility (FDA-registered, larger batches).
4. The medication ships to your door, usually with cold-chain packaging.

Why it's so much cheaper

Brand-name Wegovy and Zepbound carry list prices over $1,000/month because the manufacturers are recouping R&D and marketing costs and supplying a global supply chain. Compounding pharmacies source the active pharmaceutical ingredient (API) separately and produce smaller batches without the brand-name overhead. The cost per dose drops dramatically.

Top providers in 2026

From our best GLP-1 providers ranking:

Safety considerations

Not all compounding pharmacies are equal. Before you sign up with any telehealth provider, verify:

• The provider works with a 503A pharmacy licensed in your state OR a 503B outsourcing facility registered with the FDA
• The provider is LegitScript-certified
• The medication ships in cold-chain packaging (semaglutide and tirzepatide both require refrigeration)
• A licensed prescriber reviews your intake (not just an algorithm)

We cover red flags in detail in our compounded semaglutide safety guide. Read that before you commit to any compounded provider.

Option 2: Manufacturer Savings Cards

Both Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) operate savings programs that can dramatically reduce out-of-pocket costs.

Wegovy Savings Card (Novo Nordisk)

• Commercially insured, no Wegovy coverage: as low as $499/month for up to 13 fills
• Commercially insured, with Wegovy coverage: as low as $0/month
• Not eligible: Medicare, Medicaid, VA/Tricare, uninsured cash-pay patients

Zepbound Savings Card (Eli Lilly)

• Commercially insured, no Zepbound coverage: as low as $650/month
• Commercially insured, with Zepbound coverage: as low as $25/month
• Not eligible: Medicare, Medicaid, VA/Tricare

The key requirement for both: you need to have *commercial* (non-government) insurance, even if that insurance doesn't cover the obesity drug. The manufacturers use these savings programs to capture demand from insured patients whose plans haven't adopted GLP-1 obesity coverage.

If you are completely uninsured or on Medicare/Medicaid, you don't qualify for these savings programs and Option 1 (compounded) or Option 3 (LillyDirect) will be your best bet.

Option 3: LillyDirect Self-Pay Vials (Zepbound)

In 2024, Eli Lilly launched LillyDirect, a direct-to-consumer program offering Zepbound in single-dose vials at lower prices than the standard pre-filled pen format. Pricing in 2026:

This is brand-name Zepbound — same FDA-approved formulation, same manufacturing facility, same packaging insert. The vial format is the only difference. You self-administer with a syringe rather than a pre-filled pen.

For patients who want brand-name certainty without insurance, LillyDirect is currently the best option. It's still 2–4× the price of compounded tirzepatide, but it offers regulatory peace of mind.

Novo Nordisk launched a similar direct-to-consumer pilot for Wegovy in early 2025 — pricing is comparable but availability is more limited.

Option 4: Insurance Appeal (If Marginal Coverage Exists)

If your insurance plan technically covers obesity drugs but denied your specific claim, an appeal is worth the effort. Successful appeals typically include:

1. Documented BMI ≥30 (or ≥27 with comorbidity)
2. Failed prior weight-loss attempts (commercial program records, prior medication trials)
3. Letter of medical necessity from your prescriber
4. Comorbidity documentation (sleep apnea, hypertension, prediabetes, etc.)

We keep a state-by-state breakdown of coverage; the research article on GLP-1 coverage across commercial plans, Medicaid and Medicare has the current landscape, and call the number on your insurance card to confirm your specific plan's coverage.

What to Avoid

International pharmacies

Canadian and UK pharmacies sell Ozempic, Wegovy, Mounjaro, and Zepbound at lower prices than U.S. retail. It is illegal for U.S. patients to import most of these medications for personal use, with very narrow exceptions. The FDA has explicitly warned against this practice. Aside from the legal risk, there is no way to verify cold-chain integrity for international shipping.

"Research peptides" sold online

Numerous websites sell semaglutide and tirzepatide as "research peptides" or "not for human use" products. These are unregulated, frequently mislabeled or contaminated, and have caused multiple cases of serious adverse events. The FDA has issued warning letters to several of these vendors. Do not buy from these sources.

Off-label Ozempic for weight loss

From 2021 to 2024, many patients without diabetes obtained off-label Ozempic prescriptions. In 2026, this is much harder: PBMs require lab documentation of diabetes for Ozempic claims, and the supply allocation has shifted to prioritize Wegovy for obesity indications. Trying to game the system is more trouble than it's worth.

Putting It All Together

For most uninsured or under-insured patients in 2026, the decision tree is:

1. Do you have commercial insurance (even if it doesn't cover obesity)? Try the Wegovy or Zepbound savings card first.
2. Are you on Medicare, Medicaid, or completely uninsured? Choose between LillyDirect Zepbound vials (~$349–$599/mo, brand-name) and compounded semaglutide via telehealth (~$129–$249/mo).
3. Want the lowest possible cost? Compounded semaglutide via a verified telehealth provider, starting around $129/month.
4. Want maximum regulatory certainty? LillyDirect Zepbound vials.

Before committing to any path, plug your numbers into our GLP-1 savings calculator to see the apples-to-apples cost comparison for your specific situation. And read our compounded semaglutide safety guide before signing up with any telehealth provider — knowing what to look for is the difference between a $149/month miracle and a $149/month problem.

For a deeper look at the brand-name landscape, see our Ozempic vs Wegovy guide.